[HTML][HTML] Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker …

CM de Ravenstein, C Bouzin, S Lazam, J Boulif… - Journal of …, 2015 - Elsevier
Abstract Background Gadolinium (Gd) Extracellular volume fraction (ECV) by
Cardiovascular Magnetic Resonance (CMR) has been proposed as a non-invasive method …

Native T1 mapping and extracellular volume mapping for the assessment of diffuse myocardial fibrosis in dilated cardiomyopathy

S Nakamori, K Dohi, M Ishida, Y Goto… - JACC: Cardiovascular …, 2018 - jacc.org
Objectives: The purpose of this study was to examine the histological correlation of native
myocardial T1 and extracellular volume fraction (ECV) measurement at 3-T for the …

T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy

F aus dem Siepen, SJ Buss… - European Heart …, 2015 - academic.oup.com
Aim The aim of this study was to determine the value of extracellular volume fraction (ECV)
for the non-invasive assessment of diffuse myocardial fibrosis (MF) in different stages of …

[HTML][HTML] Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus …

EB Schelbert, SM Testa, CG Meier, WJ Ceyrolles… - Journal of …, 2011 - Elsevier
Background Myocardial extravascular extracellular volume fraction (Ve) measures quantify
diffuse fibrosis not readily detectable by conventional late gadolinium (Gd) enhancement …

[HTML][HTML] Diffuse myocardial fibrosis evaluation using cardiac magnetic resonance T1 mapping: sample size considerations for clinical trials

S Liu, J Han, MS Nacif, J Jones, N Kawel… - Journal of …, 2012 - Elsevier
Background Cardiac magnetic resonance (CMR) T1 mapping has been used to characterize
myocardial diffuse fibrosis. The aim of this study is to determine the reproducibility and …

[HTML][HTML] Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience

P Kellman, JR Wilson, H Xue, WP Bandettini… - Journal of …, 2012 - Elsevier
Background Diffuse myocardial fibrosis, and to a lesser extent global myocardial edema, are
important processes in heart disease which are difficult to assess or quantify with …

Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans

AS Flett, MP Hayward, MT Ashworth, MS Hansen… - Circulation, 2010 - Am Heart Assoc
Background—Diffuse myocardial fibrosis is a final end point in most cardiac diseases. It is
missed by the cardiovascular magnetic resonance (CMR) late gadolinium enhancement …

Native T1 relaxation time and extracellular volume fraction as accurate markers of diffuse myocardial fibrosis in heart valve Disease–comparison with targeted left …

R Kockova, P Kacer, J Pirk, J Maly, L Sukupova… - Circulation …, 2016 - jstage.jst.go.jp
Background: The aim of our study was to investigate the relationship between the cardiac
magnetic resonance (CMR)-derived native T1 relaxation time and myocardial extracellular …

Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis

LM Iles, AH Ellims, H Llewellyn, JL Hare… - European Heart …, 2015 - academic.oup.com
Aim Myocardial fibrosis is fundamental in the pathogenesis of heart failure. Late gadolinium
enhancement (LGE) with cardiac magnetic resonance (CMR) imaging is commonly …

CMR–derived extracellular volume fraction as a marker for myocardial fibrosis: the importance of coexisting myocardial inflammation

JA Lurz, C Luecke, D Lang, C Besler… - JACC: Cardiovascular …, 2018 - jacc.org
Objectives: The aim of the present study was to evaluate whether extracellular volume
fraction (ECV) can reliably inform on the extent of diffuse fibrosis in the simultaneous …